Thermo Fisher Scientific (TMO) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8835561023

Thermo Fisher Scientific Inc. is a global company that provides a wide range of solutions and services in the fields of life sciences, analytical instruments, specialty diagnostics, and laboratory products. Operating in the United States and internationally, the company serves various markets including pharmaceutical, biotechnology, agricultural, healthcare, academic, and government sectors.

One of the key segments of Thermo Fisher Scientific is the Life Sciences Solutions division, which offers reagents, instruments, and consumables for research, drug production, vaccine development, and disease diagnosis. Their product portfolio ranges from biosciences to genetic sciences, catering to a diverse array of industries.

The Analytical Instruments segment of the company provides a comprehensive suite of instruments, software, and services for laboratory, production, field, and clinical settings. These offerings are utilized by pharmaceutical companies, academic institutions, government agencies, and environmental research organizations.

Specialty Diagnostics is another important division of Thermo Fisher Scientific, specializing in immunodiagnostic reagents, blood test systems, culture media, and healthcare products. Their solutions support the clinical diagnosis and monitoring of conditions like allergy, asthma, autoimmune diseases, and organ transplant testing.

Lastly, the Laboratory Products and Biopharma Services segment of the company delivers laboratory chemicals, research materials, and pharma services to various channels. Thermo Fisher Scientific engages with customers through a variety of channels, including direct sales, customer-service professionals, e-commerce platforms, third-party distributors, and catalogs.

Established in 1956 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific Inc. continues to be a leading provider of innovative solutions for a wide range of industries. For more information, visit their website at https://www.thermofisher.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Thermo Fisher Scientific (TMO) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Thermo Fisher Scientific (TMO) - Stock & Dividends

TMO Stock Overview

Market Cap in USD 225,546m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1978-01-13

TMO Stock Ratings

Fundamental 3.86
Dividend 4.43
Growth 5y 5.97
Rel. Performance vs Sector -1.22
Analysts 4.11/5
Fair Price Momentum 566.17 USD
Fair Price DCF 497.91 USD

TMO Dividends

Yield 12m 0.25%
Yield on Cost 5y 0.53%
Dividends CAGR 5y 13.00%
Payout Consistency 36.2%

TMO Growth Ratios

Growth 12m 4.64%
Growth Correlation 12m 3%
Growth Correlation 3m 66%
CAGR 5y 16.22%
Sharpe Ratio 12m -0.03
Alpha vs SP500 12m -22.38
Beta vs SP500 5y weekly 0.81
ValueRay RSI 44.78
Volatility GJR Garch 1y 19.90%
Price / SMA 50 2.61%
Price / SMA 200 10.46%
Current Volume 1525.8k
Average Volume 20d 1473.4k

External Links for TMO Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of TMO stocks?
As of March 29, 2024, the stock is trading at USD 579.37 with a total of 1,525,832 shares traded.
Over the past week, the price has changed by -0.12%, over one month by +2.40%, over three months by +9.05% and over the past year by +3.42%.
What is the forecast for TMO stock price target?
According to ValueRays Forecast Model, TMO Thermo Fisher Scientific will be worth about 621.7 in March 2025. The stock is currently trading at 579.37. This means that the stock has a potential upside of +7.3%.
Issuer Forecast Upside
Wallstreet Target Price 597 3.04%
Analysts Target Price 601.9 3.89%
ValueRay Target Price 621.7 7.30%

Thermo Fisher Scientific Inc: A Comprehensive Overview

History and Evolution

Thermo Fisher Scientific Inc, recognized globally as a leader in serving science, has a rich history dating back to 1956. Its establishment marked the beginning of a new era in the scientific community, aiming to make the world healthier, cleaner, and safer. Through strategic mergers and acquisitions, most notably the merger of Thermo Electron and Fisher Scientific in 2006, the company expanded its reach and capabilities, positioning itself as a formidable force in the industry.

Core Business

At its core, Thermo Fisher is dedicated to helping its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity. It does so by providing a vast array of products and services. These include analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics.

Side Businesses and Expansion

While its primary focus is on serving the science community, Thermo Fisher Scientific has also branched into various side businesses. This includes the production of medical devices, pharmaceutical services, and biotechnology products. The company’s strategic acquisitions have allowed it to enter and thrive in these markets, further diversifying its business portfolio and reinforcing its market position.

Current Market Status

As of the latest market data, Thermo Fisher Scientific Inc (NYSE:TMO) continues to be a powerhouse in the science and technology sector. It has consistently shown growth in revenue and market share, thanks in part to its robust product line and strategic expansions. Despite facing challenges like global economic fluctuations and competitive pressures, Thermo Fisher has maintained its commitment to innovation, customer focus, and operational excellence. Its ability to adapt and meet the evolving needs of the scientific and healthcare communities has kept it ahead in the market.